Rational Combinations 360° addresses business aspects, clinical advancements and scientific data in IO combination strategies. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient’s immune system to eradicate cancer. Rational Combinations 360° addresses the following plenary topics over the c...
Jul 19, 2018•5 min
How to Innovate in the Drug Delivery Space What does the innovation process look likeThe barrier to the innovation process and how to overcomethemSummary of disease spaceGood design and engineering practicesHow to salvage something that goes wrong?How do you find the unknown unknowns?Does it feel right? Uri Baruch Head of Drug Delivery, Cambridge Design Partnership This talk was given at the 2018 Drug Delivery West Meeting.
Jun 23, 2018•32 min
Opening talk at Drug Delivery West, 2018 Key Trends in Drug Delivery: Expert Perspective Randall Mrsny, PhD Professor's Chair, Department of Pharmacy and Pharmacology, University of Bath
Jun 23, 2018•34 min
Patients as Partners Day 2 Session How FARA and Horizon Pharma Partnered to Improve Clinical Development and Trial Design-Case Study This session will feature how the Friedreich’s Ataxia Research Foundation collaborated with Horizon Pharma on aspects of clinical development and trial design to better understand patients living with the disease and how to better develop medicine to help manage their disease. Key areas of discussion include how they collaborated on the following: • Focus groups to...
Jun 22, 2018•33 min
This talk was given at the Patients as Partners 2018 Meeting There are many frameworks and models that exist from various organizations on aspects of patient engagement and may be challenging to navigate through when applying to your own initiatives. In this session, Takeda will walk the audience through how they used multiple patient engagement frameworks to create an internal R&D Patient Engagement Guide tailored for their drug development teams from discovery through marketed products. Th...
Jun 22, 2018•24 min
This talk was given at the Patients as Partners 2018 Meeting How Patient Research Advocates are Driving R&D: A Patient Case Study In this session, patient and research advocate, Geraldine Blavat will walk the audience through 10 steps on how patient input is integrated through the entire clinical development continuum including: Developing the Study Concept Secure Funding Preparing the Study Protocol Creating Study Procedure Implementing the Study Monitoring the Study Analyzing the Data and ...
Jun 21, 2018•26 min
John Patton, PhD, Chief Executive Officer and Chairman with Dance Biopharma and Ann Daugherty, PhD, Senior Manager, Drug Delivery with Genentech present the closing talk at Drug Delivery West, held May 21-22, 2018 in San Francisco. In this talk they discuss the lessons learned from drug delivery, what to be aware of in the future, and how to improve drug delivery methods. The next conference in Drug Delivery is the 8th annual PODD: Partnership Opportunities in Drug Delivery on October 17-18, 201...
Jun 21, 2018•39 min
Nanotechnology Keynote Address given by Omid Farokhzad, MD, Professor, Harvard Medical School and Director, Center for Nanomedicine, Brigham and Women's Hospital Omid Farokhzad is an inventor of more than 145 issued / pending patents. These for the launch of four biotechnology companies: BIND Therapeutics (acquired by Pfizer) Selecta Biosciences, Tarveda Therapeutics (formerly Blend Therapeutics) and Placon Therapeutics (spin-out from Tarveda), which are translating the aforementioned academic i...
Jun 07, 2018•33 min
Panel: Utilizing a Device Platform Technology across Multiple Therapeutic Categories Most pharma and biotech companies realize the need and benefit of having a platform device technology. The challenge then becomes figuring out how to utilize the device to deliver different types of drugs for various indications such as rheumatoid arthritis, cancer, and rare diseases. Moderator: Paul Jansen Former Associate VP Sanofi and Board Member and Senior Advisor, Haselmeier Panelists: Donna French, PhD VP...
Jun 07, 2018•36 min
The Keynote was given at Partnerships Opportunities in Drug Delivery 2017 by Lars Rebein Sorensen Former President and CEO, Novo Nordisk with Barbara Lueckel, PhD Global Business Development Director Roche Partnering Innovation, Roche
Jun 06, 2018•40 min
The expert panel of scientific leaders from industry will discuss current formulation and delivery challenges for therapeutic areas (ophthalmology, immunology, oncology infectious disease, and neurodegenerative area disorders). Each panelist will address a specific disease area and discuss the role of drug delivery in the treatment of disease. The panel will also cover currently available delivery technologies and where improvement is needed. Moderator: Ann Daugherty, PhD Senior Manager, Drug De...
Jun 05, 2018•45 min
The expert panel will address the scientific and business challenges and opportunities in this space. Panelists will discuss the difficult nature of providing therapies for diseases of the CNS, covering both device and chemistry-enabled technologies. They will also address questions such as: Can devices take us where chemistry has not?What advances being made in the field of chemis conjugation technologies?Why is intrathecal, intracerebroventricular and intraparenchymal delivery relevant for CNS...
Jun 04, 2018•49 min
Drug Delivery Needs in Oncology Due to the increasing number of parenteral biologic therapies that are administered intravenously, the already high pressure on infusion capacity and healthcare resources is expected further increase. A change from intravenous to subcutaneous dosing has been shown to reduce dosing complexity and overall drug administration related costs. There is keen interest in technologies that facilitate subcutaneous administration and potentially enable drug administration in...
Jun 04, 2018•58 min
Track 2: Clinical Operations for IO Trials This section is designed for clinical trial operation executives who want to learn what it takes to execute an IO clinical trial. This is an excellent opportunity to walk through the building blocks of IO clinical trial operations and discuss pitfalls and lessons learned. Plenary Chair: Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck This discussion was presented at the 2018 Immuno-Oncology 360° Meeting.
May 11, 2018•49 min
Building Blocks of IO Trials: This talk will consist of 7 perspectives that identify operational aspects of IO trials, including a patient perspective, site management, 3rd party component, clinical supply chain, a PI perspective, data management and project management. The collaborative talk concludes with a panel discussion and Q&A. This Discussion was presented at the 2018 Immuno-Oncology 360° Meeting.
May 10, 2018•1 hr 24 min
Endpoints News Industry Report on IO Collaborations and Trends In this episode of Pharma Talk Radio, John Carroll, Editor-in-Chief of Endpoints News, reviewed the build up of the immuno-oncology space over the past few years at the IO360° conference that took place February 2018. Mr Carroll discussed the impact the large amount of money and the extraordinary numbers that have been invested in the space, have had on collaborations. He also shed light on the natural limitations and boundaries that...
May 09, 2018•14 min
Mobile Podcast Series #2 CTTI Findings are in from their Mobile Clinical Trials Program: Recommendations on Novel Endpoints CTTI's Mobile in Clinical Trials program was launched three years ago to propose recommendations that clarify the pathway for developing novel endpoints for use in clinical trials from data generated using mobile technology. Jennifer Goldsack shares recommendations and insights from their findings on: Developing an internal process for identifying endpointsStrategies for re...
Apr 30, 2018•22 min
Podcast on Mobile in Clinical Trials Series #1 How a Mobile App Can Offer Unique Value in Assessing Patient Reported Outcomes Crescendo Biosciences's CIO, Alex Bangs, reports on how a human-centered design approach was used to create MyRA, an award-winning app for patients living with RA. This podcast comes from the 2017 Mobile in Clinical Trials US event. The next Mobile in Clinical Trials conference is May 15-16 in London and then September 24 in Boston. Mobile is the annual update on not only...
Apr 29, 2018•18 min•Season 1Ep. 1
The Chief Medical Officer Summit is delighted to present a podcast featuring the Keynote Fireside Chat with Michael Rosenblatt, MD, on Lessons Learned from the Journey of a CMO Leader In this session, Dr Rosenblatt, former Merck CMO, will share his insights on career path decision-making and will compare the experiences and lessons learned from being the CMO on the drug development side versus the biotech investor side of the industry. Moderated by CEO of Evelo Biosciences, Simba Gill, MBA, PhD....
Apr 18, 2018•45 min
The Chief Medical Officer Summit is delighted to share a podcast featuring a presentation prepared by Drs Alison Bateman-House and Arthur Caplan of NYU's Division of Medical Ethics on the topic of: Developing a Pathway for Compassionate Use Cases What should the CMO do when they receive a request?What's the role of the CMO, the FDA and the IRB?Lessons learned from Janssen Case StudyHow do you scale down for a biotech?Potential modelsCan the process be accelerated? Join us at the 6th annual Chief...
Apr 17, 2018•46 min
This podcasts gives you an overview on what to expect for the 2018 Chief Medical Officer Summit in a nutshell. The concept of the CMO Summit came from MPM Capital’s Dr Elizabeth Stoner, who told us that there is a deep need for a Summit that is designed for CMOs and heads of R&D in the emerging biotech space, specifically, where we can cover all the key issues affecting R&D decisions together with business development issues. The program takes place on May 7th and 8th at the Omni Parker ...
Apr 17, 2018•7 min
In this three minute podcast, you get an overview of one of the hottest topics we are covering in a full day 2nd annual event on Clinical Research as a Care Option. (CRAACO). Making clinical trials a care option is arguably the greatest challenge we can collaborate on in bringing patients closer to clinical trials. CRAACO takes place on April 11th at the Boston Marriott Cambridge. We look at how to integrate clinical research into the overall continuum of patient care and ask, how do we make cli...
Mar 04, 2018•3 min
This podcast gives you a five minute overview of the 3rd annual Clinical Trial Collaborations conference, otherwise known as CTC. CTC is a strategic level event focused on arguably the most important change in transforming drug development: How and who we collaborate with to drive better clinical trial outcomes? CTC is ideal for people working in clinical trial operations, who are involved with external relationships or need to be involved with external relationships and want to see examples of ...
Mar 04, 2018•5 min
The Mobile in Clinical Trials conference comes to Europe for the first time on May 15th and 16th at the Millennium Gloucester Hotel in London. If you work or want to work with mobile and digital technologies to make clinical trials more efficient and reduce patient burden, we highly recommend this conference for you. Using our past four years of experience in the US, we are able to combine the best examples of mobile and digital optimization in clinical trials from the US with examples from the ...
Mar 01, 2018•4 min
Dr Roslyn Schneider, Global Patient Affairs Lead at Pfizer, speaks with Valerie Bowling, Executive Director, Patients as Partners, in a podcast interview on patients at the center of clinical research. Dr Schneider, better known as Roz, helps drive patient centricity and the integration of the patiemt voice throughout the development of medicines at Pfizer. She gives us a brief history of the evolution of the involvement of patients in clinical research, next steps, and how patients and industry...
Mar 01, 2018•16 min
DPharm Podcast Series #5 Reducing the Burden of Type 1 Diabetes through a Model of Democratized R&D Patient advocate star, Dana Lewis, founder of OpenAPS delivers a powerful session at DPharm on an idea to reduce the burden of type 1 diabetes with a smart system she created through open soucre. Learn how she drive the idea and creation of the "Self driving car for diabetes". The next DPharm conference is September 25-26 in Boston. DPharm reports on innovation and disruptive innovation to adv...
Feb 19, 2018•28 min•Ep. 5
5th Annual Patients as Partners What to Expect Overview Podcast Officially approved by Patients Included, Patients as Partners is the only program in the US that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. Taking place March 15-16 in Philadelphia, the focus of this year’s program is on turning discussion into action, and Kate Woda, the Conference Director has worked meticulously with the adv...
Feb 19, 2018•7 min
DPharm podcast series # 2 MIT Professor, Dina Katabi, PhD gave one of the best talks on in home non-intrusive patient monitoring at DPharm 2017 and provided a demo of technology that uses ambient radio signals to monitor a patient’s gait, falls, breathing, heart rate and even sleep, all without putting any sensor on the patient’s body. Find out how they have used the technology to redefine clinical endpoints and pushed clinical trials to the home. The next DPharm conference is September 25-26 in...
Feb 17, 2018•29 min•Ep. 2
The Conference Forum presents a 1 day meeting on Immuno-Oncology Clinical Trial Operations, February 8th at the Roosevelt hotel in NYC. It’s part of the IO360 conference, which runs over three days from Feb 7th through the 9th. The OPERATIONS portion of this conference is offered as a stand alone program. This podcast gives a brief summary of what to expect. The morning provides first hand reporting on new trends and emerging technologies. The afternoon goes through 7 components including: the p...
Jan 28, 2018•4 min
The 2nd annual Patients as Partners EU is the only conference in Europe that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. In this short podcast, Valerie Bowling, executive director at the Conference Forum gives a brief summary of what to expect at this conference and runs through the highlights. Chairs: Tony Hoos, MD, PhD, MBA Head of Medical, Amgen Europe Andrew Garvey Global Patient Advocacy Lead...
Dec 27, 2017•3 min
